Combined REgenerative Therapy (Local InSulin + Platelet Rich Fibrin) and Topical Oxygen TheRapy for improving long term outcomEs in patients with Diabetic Foot Ulcers: a multicenter, open 2×2 factorial randomized controlled trial. [RESTORE-DFU RCT].
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2026 - 2028
Project Lead
Authors
Dr Belinda George, Dr Deepak Kamath, Dr. Anindya Debnath
Project Status
ongoing
Project Type
Multicentric RCT